PubMed

Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.

Okada T, Wada J, Hida K, Eguchi J, Hashimoto I, Baba M, Yasuhara A, Shikata K, Makino H.

Diabetes. 2006 Jun;55(6):1666-77.PMID: 16731829 [PubMed - indexed for MEDLINE]Related articlesFree article

Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.

Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.

J Am Soc Nephrol. 2005 Nov;16(11):3222-34. Epub 2005 Sep 21.PMID: 16177004 [PubMed - indexed for MEDLINE]Related articlesFree article

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR.

Nephrol Dial Transplant. 2008 Sep;23(9):2750-60. Epub 2008 Apr 3.PMID: 18388116 [PubMed - indexed for MEDLINE]Related articles

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells.

Panchapakesan U, Pollock CA, Chen XM.

Am J Physiol Renal Physiol. 2004 Sep;287(3):F528-34. Epub 2004 Apr 27.PMID: 15113752 [PubMed - indexed for MEDLINE]Related articlesFree article

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H, Wada J, Shikata Y, Makino H.

Am J Physiol Renal Physiol. 2007 Apr;292(4):F1141-50. Epub 2006 Dec 26.PMID: 17190910 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes.

Rüster C, Bondeva T, Franke S, Förster M, Wolf G.

Nephrol Dial Transplant. 2008 Jul;23(7):2179-91. Epub 2008 Mar 14.PMID: 18344241 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.

Xu ZG, Yoo TH, Ryu DR, Cheon Park H, Ha SK, Han DS, Adler SG, Natarajan R, Kang SW.

Kidney Int. 2005 Mar;67(3):944-52.PMID: 15698433 [PubMed - indexed for MEDLINE]Related articles

Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.

Zafiriou S, Stanners SR, Saad S, Polhill TS, Poronnik P, Pollock CA.

J Am Soc Nephrol. 2005 Mar;16(3):638-45. Epub 2005 Feb 2.PMID: 15689403 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.

Yang HC, Ma LJ, Ma J, Fogo AB.

Kidney Int. 2006 May;69(10):1756-64. Erratum in: Kidney Int. 2007 Feb;71(4):366. PMID: 16598202 [PubMed - indexed for MEDLINE]Related articles

The lack of cyclin kinase inhibitor p27(Kip1) ameliorates progression of diabetic nephropathy.

Awazu M, Omori S, Ishikura K, Hida M, Fujita H.

J Am Soc Nephrol. 2003 Mar;14(3):699-708.PMID: 12595506 [PubMed - indexed for MEDLINE]Related articlesFree article

PPAR-gamma agonist protects podocytes from injury.

Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB.

Kidney Int. 2007 Jun;71(12):1232-9. Epub 2007 Apr 25.PMID: 17457378 [PubMed - indexed for MEDLINE]Related articles

Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.

Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR.

Nephrol Dial Transplant. 2009 Jan;24(1):73-84. Epub 2008 Aug 5.PMID: 18682491 [PubMed - indexed for MEDLINE]Related articles

Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.

Nishiyama A, Nakagawa T, Kobori H, Nagai Y, Okada N, Konishi Y, Morikawa T, Okumura M, Meda I, Kiyomoto H, Hosomi N, Mori T, Ito S, Imanishi M.

J Hypertens. 2008 Sep;26(9):1849-59.PMID: 18698221 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus.

Bajaj M, Suraamornkul S, Hardies LJ, Glass L, Musi N, DeFronzo RA.

Diabetologia. 2007 Aug;50(8):1723-31. Epub 2007 May 23.PMID: 17520238 [PubMed - indexed for MEDLINE]Related articles

Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.

Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.

J Nephrol. 2003 Nov-Dec;16(6):841-9.PMID: 14736011 [PubMed - indexed for MEDLINE]Related articles

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.

Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M.

Lab Invest. 2002 Jan;82(1):25-35.PMID: 11796823 [PubMed - indexed for MEDLINE]Related articles

Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1.

Redondo S, Hristov M, Gümbel D, Tejerina T, Weber C.

Thromb Haemost. 2007 Jun;97(6):979-87.PMID: 17549301 [PubMed - indexed for MEDLINE]Related articles

Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.

Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X.

Nephrology (Carlton). 2006 Dec;11(6):516-23.PMID: 17199790 [PubMed - indexed for MEDLINE]Related articles

Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.

Lin MS, Chen WC, Bai X, Wang YD.

J Dig Dis. 2007 May;8(2):82-8.PMID: 17532820 [PubMed - indexed for MEDLINE]Related articles